Selected article for: "activity integrase and integrase protease"

Author: Wang, Xiaoli; Wang, Jiao; Zhang, Wenmei; Li, Boye; Zhu, Ying; Hu, Qin; Yang, Yishu; Zhang, Xiaoguang; Yan, Hong; Zeng, Yi
Title: Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate
  • Document date: 2018_5_16
  • ID: 1ghbutov_40
    Snippet: We further examined the ability of PT-1 to inhibit the viral protease, reverse transcriptase and integrase. Pepstatin A, nevirapine (NVP), and RAL were used as positive controls, respectively. PT-1 did not suppress protease activity ( Figure 5A ) but blocked reverse transcriptase activity ( Figure 5B ) and HIV-1 integrase 3′ processing ( Figure 5C ) only at the highest concentration (17.6 µM). The maximum inhibition rates of reverse transcript.....
    Document: We further examined the ability of PT-1 to inhibit the viral protease, reverse transcriptase and integrase. Pepstatin A, nevirapine (NVP), and RAL were used as positive controls, respectively. PT-1 did not suppress protease activity ( Figure 5A ) but blocked reverse transcriptase activity ( Figure 5B ) and HIV-1 integrase 3′ processing ( Figure 5C ) only at the highest concentration (17.6 µM). The maximum inhibition rates of reverse transcriptase and integrase 3′ processing were approximately 70% and 60%, respectively. These data implied that in vitro reduction of reverse transcriptase and integrase activity was unlikely to be major mechanism of PT-1 induced HIV-1 inhibition at nanomolar concentrations.

    Search related documents:
    Co phrase search for related documents
    • high concentration and nanomolar concentration: 1, 2
    • high concentration and positive control: 1, 2, 3, 4, 5, 6
    • high concentration and protease activity: 1
    • high concentration and reverse transcriptase: 1
    • high concentration and viral protease: 1
    • high concentration and viral protease inhibit: 1
    • high concentration and vitro reduction: 1, 2
    • inhibition rate and positive control: 1, 2
    • inhibition rate and protease activity: 1
    • integrase activity and major mechanism: 1
    • integrase activity and NVP nevirapine: 1, 2
    • integrase activity and positive control: 1, 2, 3
    • integrase activity and processing integrase: 1, 2, 3
    • integrase activity and protease activity: 1, 2
    • integrase activity and RAL positive control: 1, 2, 3
    • integrase activity and reverse transcriptase: 1, 2, 3, 4, 5, 6
    • integrase activity and reverse transcriptase integrase activity: 1, 2
    • integrase activity and reverse transcriptase integrase activity vitro reduction: 1
    • integrase activity and transcriptase activity: 1, 2, 3, 4